Tenvir
Tenvir

4.11
Used to address viral conditions, this generic medicine disrupts the replication cycle of viral particles. Aids in lowering viral loads by preventing the integration of viral genetic material.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tenofovir disoproxil fumarate
Reference Brand
Tenofovir
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals, Antivirals, Hepatitis Treatment
Product Category
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Pharmacological Class
NRTI
Manufacturer Description
Developed to mitigate viral replication to support immune CD4 counts and target hepatitis B viral liver safety.
Mechanism of Action
Inhibits viral reverse transcriptase and DNA polymerase, leading to termination of the viral DNA chain.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Severe renal impairment, Hypersensitivity to tenofovir
Severe Adverse Events
Lactic acidosis — requires immediate medical attention, Severe acute hepatitis B flare — requires immediate medical attention
Common Side Effects
Nausea, Headache, Fatigue
Uncommon Side Effects
Renal impairment, Bone density decrease, Diarrhea
Drug Interactions
Acyclovir, Didanosine, NSAIDs
Pregnancy Safety Warnings
TGA Category B: Safety established. Essential therapy component. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for patients over two years of age and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Tenvir is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Hay Fever Treatment - Telfast Price